It is known that upregulation of programed cell death-ligand 1 (PD-L1) on cancer cells inhibits immune intervention by binding to its specific receptor programed cell death protein 1 (PD1), expressed on activated T cells [36]. This evidence concerns the gene CD274 and cancer.